| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 175,141 | 254,659 | ||
| Accounts receivable, net of allowance for credit losses of 0 and 0, respectively | 8,251 | 8,251 | ||
| Other current assets | 11,040 | 15,869 | ||
| Total current assets | 194,432 | 278,779 | ||
| Patents, net of accumulated amortization of 4,268,873 and 3,048,750, respectively | 10,818,127 | 11,405,992 | ||
| Total assets | 11,012,559 | 11,684,771 | ||
| Accounts payable and accrued liabilities (0 and 11,041 due to related parties, respectively) | 133,218 | 206,096 | ||
| Loans payable | 138,000 | 138,000 | ||
| Funding liability | 17,798,856 | 17,384,381 | ||
| Loan payable - related party-Related Party | 2,796,500 | 2,796,500 | ||
| Warrant liability | 131,856 | 90,951 | ||
| Accrued interest | 1,708,440 | 1,532,845 | ||
| Total current liabilities | 22,706,870 | 22,148,773 | ||
| Loan payable sba | 150,000 | 150,000 | ||
| Purchase price of patents | 53,665 | 53,665 | ||
| Total liabilities | 22,910,535 | 22,352,438 | ||
| Common stock, par value 0.00003 per share authorized 30,000,000 at september 30, 2025 and december 31, 2024 5,331,973 shares issued and outstanding at september 30, 2025 and december 31, 2024 | 160 | 160 | ||
| Additional paid-in capital | 17,680,793 | 17,680,793 | ||
| Accumulated deficit | -29,579,157 | -28,348,848 | ||
| Total quest patent research corporation stockholders deficit | -11,898,204 | -10,667,895 | ||
| Non-controlling interest in subsidiary | 228 | 228 | ||
| Total stockholders deficit | -11,897,976 | -10,667,667 | ||
| Total liabilities and stockholders deficit | 11,012,559 | 11,684,771 | ||
QUEST PATENT RESEARCH CORP (QPRC)
QUEST PATENT RESEARCH CORP (QPRC)